Thymia Limited

Thymia Limited is a United Kingdom company headquartered in London that positions itself as a health and safety intelligence layer for voice. Rather than performing transcription or sentiment analysis, Thymia analyses the biological signal contained in sound, aiming to make it actionable. According to its official website, the platform can derive more than 30 voice biomarkers from as little as 15 seconds of speech, in real time. The company frames voice as an increasingly dominant interface across artificial intelligence, healthcare, vehicles and safety-critical systems, while arguing that conventional voice AI only understands content and is blind to health signals. Thymia's stated purpose is to instrument voice the way heart rate, blood oxygen, movement and facial expression have already been instrumented, so that early warnings of conditions such as depression, fatigue and burnout can be detected before crises occur. Thymia's website highlights example use cases and indicative detection figures, including depression at 86%, fatigue at 72% and burnout at 61%. It describes billions of daily conversations across telehealth, AI agents, vehicles, contact centres and emergency lines, and argues that health and safety intelligence needs to be built in rather than bolted on. The company presents itself as infrastructure for real-time health intelligence rather than as a single end-user application. As a corporate entity, Thymia Limited is recorded as a company in London, United Kingdom. It operates a public website at thymia.ai and publishes technical documentation, along with information on ethics and anonymity and a trust centre, signalling an emphasis on responsible handling of sensitive voice-health data. The company is privately held; no parent company, owner or stock listing is indicated in the available evidence.

Thymia Limited is a company based in London, United Kingdom. Public evidence available for this dossier is limited to the company's own website and a Wikidata record identifying it as a company in London; no founding date, founder names, funding history or corporate milestones are provided in the supplied sources. What can be established is the company's product direction. Thymia has built and markets a voice-analysis platform that it describes as a health and safety intelligence layer for voice. The company explicitly distinguishes its technology from transcription and sentiment analysis, stating that it works on the biological signal contained in sound and makes that signal actionable. Its headline capability is the extraction of more than 30 voice biomarkers from as little as 15 seconds of speech, in real time. Thymia situates its technology within a broad set of environments where voice is used: telehealth, AI agents, vehicles, contact centres and emergency lines. It argues that while other human signals such as heart rate, blood oxygen, movement and facial expression have been instrumented, voice remains largely unread by existing voice AI, which hears words but misses health-relevant information. The company's stated mission is therefore to build health and safety intelligence into voice systems rather than adding it afterwards. The website presents indicative detection figures for specific conditions, including depression at 86%, fatigue at 72% and burnout at 61%, and warns that millions of early warnings go undetected every day. Thymia also maintains technical documentation and publishes material on ethics and anonymity alongside a trust centre, reflecting the sensitivity of processing voice data for health purposes. Beyond these points, the available evidence does not disclose Thymia's incorporation details, leadership, investors or commercial partnerships. The dossier should be treated as a product-and-positioning profile rather than a full corporate history until further sources are available.

Infrastructure layer for real-time health and safety intelligence derived from voice, positioned as complementary to and beyond transcription and sentiment analysis.

• Voice biomarker platform

  A real-time platform that extracts 30+ voice biomarkers from 15 seconds of speech, positioned as a health and safety intelligence layer rather than transcription or sentiment analysis.

• Real-time health intelligence infrastructure

  Infrastructure intended to be built into voice systems across telehealth, AI agents, vehicles, contact centres and emergency lines.

1. 1thymiathymia.ai
2. 2Thymia Limited (United Kingdom) - Wikidatawikidata.org